Parmax Pharma Limited Share Price

₹ 133.70

-₹1.35 (-1%)
1D
Last updated 02 Nov, 2026, 14:54 IST
BSE: 540359
|
Pharmaceuticals

Parmax Pharma Limited Share Price Today

As of 9 Nov 2026, Parmax Pharma Limited share price is ₹133.70. The stock opened at ₹135.05, compared to its previous close of ₹135.05. During today's trading session, Parmax Pharma Limited share price moved in the range of ₹133.70 to ₹135.05, with an average price of ₹134.38 for the day. Looking at its last 52-week, the stock has touched a low of ₹22.60 and a high of ₹139.10.

₹133.70
1.00% down today
₹135.05
1D LOW
1D HIGH

Parmax Pharma Limited Stock Insights

Stock Performance
OutperformingBeat Nifty by 30.97 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 109.91%
Parmax Pharma Limited stock performance
Open₹135.05
High₹135.05
Low₹133.70
Prev. close₹135.05
Parmax Pharma Limited trading activity
Volume33,819
Average traded price₹133.99
Last traded time02:54:52 02 Nov
Last traded quantity486
Circuit
L
H
₹132.40
₹135.00
52-week
L
H
₹22.60
₹139.10
Mkt Cap Cr
91.97
P/E
-76.84
P/B
20.02
ROA
-4.24%
ROE
67.65%
ROCE
-85.76%
Quick Ratio
0.39
EV/EBITDA
-272.05

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Parmax Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Parmax Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,59,496.6440.625.09.61%13.79%18.65%2.3123.35
Divis Laboratories2,73,565.3787.4716.3413.32%15.32%19.56%3.562.27
Torrent Pharmaceuticals1,81,473.5086.469.884.7%11.42%11.37%0.7534.53
Laurus Labs1,26,162.9096.1121.1311.58%22.11%20.91%0.6853.3
Zydus Lifesciences1,19,201.7127.714.297.63%15.1%14.86%0.9116.0
Dr. Reddy's Laboratories1,14,532.4441.52.954.79%7.21%8.58%1.3519.35
Cipla1,13,988.9739.883.226.6%8.18%10.8%2.521.52
Mankind Pharma1,04,913.4546.355.977.82%12.76%14.68%0.7425.47
Aurobindo Pharma1,03,395.4125.932.626.46%10.13%12.76%1.1512.49
Lupin91,001.3117.433.7813.08%21.65%24.54%1.4210.19

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Parmax Pharma Limited Company Background

ISIN
INE240T01014
Sector Market Cap
₹ 91.97 Cr

Parmax Pharma Ltd is an India-based company, which is engaged in active pharmaceutical ingredients (API) and contract manufacturing operations (CMO) business. It uses quality by design techniques to produce complex molecules enabling customers to create formulations. The Company’s manufacturing units run in accordance with current good manufacturing practices (cGMP). Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Ormeloxifene Hydrochloride I.P., Milnacipram HCl, Calciumpoly Carbophil usp, Levosulpride, Paliperidone, Edaravone, Lacosamide, Iloperidone, Prasugrel HCl, 2-Acetyl Thiophene, Morpholine Hydrochloride, Camphor Sulfonyl Chloride, ISB-I (2-Chlorobenzaldehyde-5-Sulfonic acid disodium salt), Benzaldehyde-2, 5-Di-Sulfonic acid disodium salt, 2-picolinoxylidide, 4-Octyl amino pyridine (4-OAP), Sitagliptin phosphate Monohydrate API, Solifenacin Succinate API, Vilazodone Hydrochloride API, and Azelnidipine API.

Parmax Pharma Limited Financial Highlights

  • Revenue: Parmax Pharma Limited reported revenue of ₹12.16 crore in FY26 vs ₹28.24 crore in FY25. It showed a decrease of 56.94% on a yearly basis.
  • Operating Profit: Parmax Pharma Limited reported an operating loss of ₹5.85 crore in FY26 vs ₹2.40 crore in FY25. It showed a decrease of 143.75% on a year-on-year basis.
  • Net Profit: Parmax Pharma Limited reported a net loss of ₹4.16 crore in FY26 vs ₹2.09 crore in FY25. It showed a decrease of 99.04% on a yearly basis.

Parmax Pharma Limited Quarterly Result Highlights

  • Parmax Pharma Limited reported revenue of ₹10.30 crore in Jun 2026, compared with ₹3.34 crore in Mar 2026, representing an increase of 208.38% on a quarter-on-quarter (QoQ) basis.
  • Parmax Pharma Limited reported an operating profit of ₹2.20 crore in Jun 2026, compared with ₹2.27 crore in Mar 2026, representing an increase of 196.92% on a quarter-on-quarter (QoQ) basis.
  • Parmax Pharma Limited reported a profit of ₹2.20 crore in Jun 2026, compared with ₹0.58 crore in Mar 2026, reflecting an increase of 479.31% on a QoQ basis.
  • The earnings per share (EPS) of Parmax Pharma Limited stood at ₹11.00 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
64.66%
FII
0.00%
Other DII
0.00%
Retail and other
35.34%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

Parmax Pharma Limited Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

Parmax Pharma Limited Share Price History

Parmax Pharma Limited share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹135.05 / ₹133.70
-1.00%
26 Oct 26
₹135.05 / ₹135.05
-0.99%
19 Oct 26
₹136.40 / ₹136.40
-0.98%
12 Oct 26
₹139.10 / ₹137.75
-0.97%
Show more

Parmax Pharma Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹12.11₹28.20₹11.05₹15.42
Other Income₹0.05₹0.04₹0.05₹0.04
Total Revenue₹12.16₹28.24₹11.10₹15.46
Total Expenses₹18.00₹29.57₹16.76₹15.42
Profit Before Tax-₹5.85-₹2.40-₹5.66₹0.05
Tax-₹1.69-₹0.30₹0.09₹0.15
Profit After Tax-₹4.16-₹2.09-₹5.75-₹0.10
EPS - Basic-₹11.00-₹6.00-₹34.56-₹0.28
EPS - Diluted-₹11.00-₹6.00-₹34.56-₹0.28

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹4.16-₹2.09-₹5.66₹0.05
Income before WC changes-₹4.83-₹0.29-₹4.07₹1.74
Change in Assets-₹7.17-₹4.19₹1.80-₹1.23
Change in Liabilities₹9.65₹3.83₹2.08-₹0.18
Change in WC₹2.48-₹0.36₹3.88-₹1.41
Cash flow from Operations-₹2.36-₹0.66-₹0.20₹0.33
Cash flow from Investing-₹0.90-₹0.70-₹1.59-₹0.94
Cash flow from Financing₹3.81₹1.40₹1.43-₹0.04
Total Cash Flow₹0.56₹0.04-₹0.36-₹0.65
Cash (Start of the year)₹0.09₹0.05₹0.41₹1.05
Cash (End of the year)₹0.65₹0.09₹0.05₹0.41

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹11.37₹9.81₹9.56₹10.08
Current Assets₹16.68₹8.94₹5.77₹7.53
Total Assets₹28.05₹18.75₹15.33₹17.61
Current Liabilities₹22.68₹13.04₹9.21₹7.14
Net Current Asset-₹6.00-₹4.10-₹3.44₹0.39
Non-Current Liabilities₹11.52₹7.70₹6.01₹4.62
Equity Capital-₹6.15-₹1.99₹0.11₹5.86
Total Equity & Liabilities₹28.05₹18.75₹15.33₹17.61
* All values are in INR Crore
Parmax Pharma Limited market depth
Bid quantityBid priceAsk priceAsk quantity
00133.71542
0000
0000
0000
0000
Total bid quantity0
Total ask quantity1,542
Parmax Pharma Limited technical summary
Bearish indicators1
Neutral indicators3
Bullish indicators4
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
72.34
Bullish
ATR (14)
1.67
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
67
Bearish
UO(9)
60.86
Neutral
ROC(12)
4.95
Bullish
WillR(14)
-38.16
Neutral
Period
Simple value
Exponential vaue
5D
136.4
135.31
10D
135.74
133.97
20D
128.54
128.2
50D
109.99
109.86
100D
76.74
87.91
Volume trend — traded volume by day
2 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Parmax Pharma Limited
Pharmaceuticals
Add Stock
Add Another

Parmax Pharma Limited Returns Calculator

Top Gainers

FINCABLES Share Price
₹1309.00
+218 (+19.98%)
RRKABEL Share Price
₹2115.40
+194.5 (+10.13%)
HAPPYFORGE Share Price
₹1863.90
+169.4 (+10%)
DIVISLAB Share Price
₹11097.00
+776.5 (+7.52%)
ZEEL Share Price
₹68.42
+4.45 (+6.96%)
See more

Top Losers

HBLENGINE Share Price
₹801.30
-37.95 (-4.52%)
VOLTAS Share Price
₹1056.50
-42.5 (-3.87%)
CONCORDBIO Share Price
₹612.20
-20.4 (-3.22%)
RATNAMANI Share Price
₹2408.00
-47.9 (-1.95%)
STLTECH Share Price
₹706.25
-13.65 (-1.9%)
See more

Parmax Pharma Limited Share Price FAQs

Please be aware that Parmax Pharma Limited stock prices are subject to continuous fluctuations due to various factors.